Imprime Pgg, a Novel Immune Modulator, in the 1St-Line Treatment of Stage Iv Nsclc: Results from a Randomized, Controlled, Multicenter Phase 2 Study
Gespeichert in:
| Veröffentlicht in: | Annals of oncology 2014-09, Vol.25, p.v1 |
|---|---|
| Hauptverfasser: | , , , , , , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | |
|---|---|
| container_issue | |
| container_start_page | v1 |
| container_title | Annals of oncology |
| container_volume | 25 |
| creator | Engel-Riedel, W. Schneller, F. Wolf, M. Schuette, W. Lowe, J. Mattson, P. Gargano, M. Patchen, M.L. Huhn, R.D. Braun, A. |
| description | |
| doi_str_mv | 10.1093/annonc/mdu438.35 |
| format | Article |
| fullrecord | <record><control><sourceid>crossref</sourceid><recordid>TN_cdi_crossref_primary_10_1093_annonc_mdu438_35</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>10_1093_annonc_mdu438_35</sourcerecordid><originalsourceid>FETCH-LOGICAL-c885-51ee8df1b8aa7846d046265bfff84cca76b1c140649486911d41a6b5fcba5e243</originalsourceid><addsrcrecordid>eNotkMtuwjAURL1opVLafZf3AwjYsR2c7irURySgCNhHjh-QKrErO0Gi39EPbhBdzUgzOouD0BPBU4JzOpPOeadmre4ZFVPKb9AI5ylN5pyyO3Qf4xfGOMvTfIR-i_Y71K2BzeEwAQlrfzINFG3bOwMrr_tGdj5MoHbQHQ2QXZcs62HaByO71rgOvIVdJw8GihOso2rUM2xN7Jsugg2-HZhb6bRv6x-jJ7Dwrgu-aS59NZxqNTBMgM1RRgPpgOr1-QHdWtlE8_ifY7R_e90vPpLl53uxeFkmSgiecGKM0JZUQsq5YJnGLEszXllrBVNKzrOKKMJwxnImspwQzYjMKm5VJblJGR0jfMWq4GMMxpYXFTKcS4LLi8jyKrK8iiwpp396h2wt</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Imprime Pgg, a Novel Immune Modulator, in the 1St-Line Treatment of Stage Iv Nsclc: Results from a Randomized, Controlled, Multicenter Phase 2 Study</title><source>EZB-FREE-00999 freely available EZB journals</source><source>Alma/SFX Local Collection</source><creator>Engel-Riedel, W. ; Schneller, F. ; Wolf, M. ; Schuette, W. ; Lowe, J. ; Mattson, P. ; Gargano, M. ; Patchen, M.L. ; Huhn, R.D. ; Braun, A.</creator><creatorcontrib>Engel-Riedel, W. ; Schneller, F. ; Wolf, M. ; Schuette, W. ; Lowe, J. ; Mattson, P. ; Gargano, M. ; Patchen, M.L. ; Huhn, R.D. ; Braun, A.</creatorcontrib><identifier>ISSN: 0923-7534</identifier><identifier>DOI: 10.1093/annonc/mdu438.35</identifier><language>eng</language><ispartof>Annals of oncology, 2014-09, Vol.25, p.v1</ispartof><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c885-51ee8df1b8aa7846d046265bfff84cca76b1c140649486911d41a6b5fcba5e243</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>315,781,785,27929,27930</link.rule.ids></links><search><creatorcontrib>Engel-Riedel, W.</creatorcontrib><creatorcontrib>Schneller, F.</creatorcontrib><creatorcontrib>Wolf, M.</creatorcontrib><creatorcontrib>Schuette, W.</creatorcontrib><creatorcontrib>Lowe, J.</creatorcontrib><creatorcontrib>Mattson, P.</creatorcontrib><creatorcontrib>Gargano, M.</creatorcontrib><creatorcontrib>Patchen, M.L.</creatorcontrib><creatorcontrib>Huhn, R.D.</creatorcontrib><creatorcontrib>Braun, A.</creatorcontrib><title>Imprime Pgg, a Novel Immune Modulator, in the 1St-Line Treatment of Stage Iv Nsclc: Results from a Randomized, Controlled, Multicenter Phase 2 Study</title><title>Annals of oncology</title><issn>0923-7534</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2014</creationdate><recordtype>article</recordtype><recordid>eNotkMtuwjAURL1opVLafZf3AwjYsR2c7irURySgCNhHjh-QKrErO0Gi39EPbhBdzUgzOouD0BPBU4JzOpPOeadmre4ZFVPKb9AI5ylN5pyyO3Qf4xfGOMvTfIR-i_Y71K2BzeEwAQlrfzINFG3bOwMrr_tGdj5MoHbQHQ2QXZcs62HaByO71rgOvIVdJw8GihOso2rUM2xN7Jsugg2-HZhb6bRv6x-jJ7Dwrgu-aS59NZxqNTBMgM1RRgPpgOr1-QHdWtlE8_ifY7R_e90vPpLl53uxeFkmSgiecGKM0JZUQsq5YJnGLEszXllrBVNKzrOKKMJwxnImspwQzYjMKm5VJblJGR0jfMWq4GMMxpYXFTKcS4LLi8jyKrK8iiwpp396h2wt</recordid><startdate>201409</startdate><enddate>201409</enddate><creator>Engel-Riedel, W.</creator><creator>Schneller, F.</creator><creator>Wolf, M.</creator><creator>Schuette, W.</creator><creator>Lowe, J.</creator><creator>Mattson, P.</creator><creator>Gargano, M.</creator><creator>Patchen, M.L.</creator><creator>Huhn, R.D.</creator><creator>Braun, A.</creator><scope>AAYXX</scope><scope>CITATION</scope></search><sort><creationdate>201409</creationdate><title>Imprime Pgg, a Novel Immune Modulator, in the 1St-Line Treatment of Stage Iv Nsclc: Results from a Randomized, Controlled, Multicenter Phase 2 Study</title><author>Engel-Riedel, W. ; Schneller, F. ; Wolf, M. ; Schuette, W. ; Lowe, J. ; Mattson, P. ; Gargano, M. ; Patchen, M.L. ; Huhn, R.D. ; Braun, A.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c885-51ee8df1b8aa7846d046265bfff84cca76b1c140649486911d41a6b5fcba5e243</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2014</creationdate><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Engel-Riedel, W.</creatorcontrib><creatorcontrib>Schneller, F.</creatorcontrib><creatorcontrib>Wolf, M.</creatorcontrib><creatorcontrib>Schuette, W.</creatorcontrib><creatorcontrib>Lowe, J.</creatorcontrib><creatorcontrib>Mattson, P.</creatorcontrib><creatorcontrib>Gargano, M.</creatorcontrib><creatorcontrib>Patchen, M.L.</creatorcontrib><creatorcontrib>Huhn, R.D.</creatorcontrib><creatorcontrib>Braun, A.</creatorcontrib><collection>CrossRef</collection><jtitle>Annals of oncology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Engel-Riedel, W.</au><au>Schneller, F.</au><au>Wolf, M.</au><au>Schuette, W.</au><au>Lowe, J.</au><au>Mattson, P.</au><au>Gargano, M.</au><au>Patchen, M.L.</au><au>Huhn, R.D.</au><au>Braun, A.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Imprime Pgg, a Novel Immune Modulator, in the 1St-Line Treatment of Stage Iv Nsclc: Results from a Randomized, Controlled, Multicenter Phase 2 Study</atitle><jtitle>Annals of oncology</jtitle><date>2014-09</date><risdate>2014</risdate><volume>25</volume><spage>v1</spage><pages>v1-</pages><issn>0923-7534</issn><doi>10.1093/annonc/mdu438.35</doi></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0923-7534 |
| ispartof | Annals of oncology, 2014-09, Vol.25, p.v1 |
| issn | 0923-7534 |
| language | eng |
| recordid | cdi_crossref_primary_10_1093_annonc_mdu438_35 |
| source | EZB-FREE-00999 freely available EZB journals; Alma/SFX Local Collection |
| title | Imprime Pgg, a Novel Immune Modulator, in the 1St-Line Treatment of Stage Iv Nsclc: Results from a Randomized, Controlled, Multicenter Phase 2 Study |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-14T02%3A51%3A18IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-crossref&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Imprime%20Pgg,%20a%20Novel%20Immune%20Modulator,%20in%20the%201St-Line%20Treatment%20of%20Stage%20Iv%20Nsclc:%20Results%20from%20a%20Randomized,%20Controlled,%20Multicenter%20Phase%202%20Study&rft.jtitle=Annals%20of%20oncology&rft.au=Engel-Riedel,%20W.&rft.date=2014-09&rft.volume=25&rft.spage=v1&rft.pages=v1-&rft.issn=0923-7534&rft_id=info:doi/10.1093/annonc/mdu438.35&rft_dat=%3Ccrossref%3E10_1093_annonc_mdu438_35%3C/crossref%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |